SMTL ID : 3bys.1

co-crystal structure of Lck and aminopyrimidine amide 10b

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.20 Å

Oligo State

monomer

Ligands

1 x AM5: 4-methyl-N~3~-(2-{[4-(4-methylpiperazin-1-yl)phenyl]amino}pyrimidin-5-yl)-N~1~-[3-(trifluoromethyl)phenyl]benzene-1,3-dicarboxamide(Non-covalent)

AM5.1: 23 residues within 4Å: Chain A: L.27, V.35, A.47, V.48, K.49, E.64, M.68, L.76, I.90, T.92, E.93, Y.94, M.95, E.96, G.98, I.131, Y.136, H.138, L.147, I.156, A.157, D.158, F.159 12 PLIP interactions: 12 interactions with chain A Hydrophobic interactions: A:K.49, A:E.64, A:I.90, A:T.92, A:Y.94, A:L.147, A:D.158 Hydrogen bonds: A:E.64, A:T.92, A:M.95, A:M.95, A:D.158

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

DiMauro, E.F. et al., Structure-guided design of aminopyrimidine amides as potent, selective inhibitors of lymphocyte specific kinase: synthesis, structure-activity relationships, and inhibition of in vivo T cell activation. J.Med.Chem. (2008)

Release Date

2008-09-16

Peptides

Proto-oncogene tyrosine-protein kinase LCK: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Proto-oncogene tyrosine-protein kinase LCK

Related Entries With Identical Sequence